Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Review - (2018) Volume 9, Issue 4

Heart Rate Variability (HRV)

Karishma Rajbhandari Panday1* and Dipesh Raj Panday2
1Department of Basic and Clinical Physiology, BP Koirala Institute of Health Sciences (BPKIHS), Nepal
2Department of Clinical Pharmacology and Therapeutics, BP Koirala Institute of Health Sciences (BPKIHS), Nepal
*Corresponding Author: Karishma Rajbhandari Panday, Assistant Professor, Department of Basic and Clinical Physiology, BP Koirala Institute of Health Sciences (BPKIHS), Nepal, Tel: + 9779862124700 Email:

Abstract

Heart rate is mainly determined by pacemaker current generated in the SA node. It, in turn, is regulated by autonomic nervous system. Sympathetic stimulation enhances chronotropic, ionotropic and dromotropic activity via α and β receptor activation whereas, parasympathetic stimulation causes reverse effect on heart via the M2 receptors. Varied input from these two branches of the ANS produces change in heart rate. So, HRV, therefore, is the change in the time interval between two consecutive heartbeats. In other words, HRV is the time difference between a given heart beat to the mean duration of heartbeat.
Like all other organs of the body, heart is also susceptible to aging and diseases. These conditions influence heart rate and also HRV.
Today, HRV has invited much investigation and debate. Electronic databases Google Scholar, IMSEAR (Index Medicus for South-East Asia Region), Scopemed and MEDLINE/PubMed were extensively explored with key words “HRV” or “Heart Rate Variability” from earliest possible date (1973) to December, 2016 and the available information summarized. Different aspects of HRV have been covered including historical background, HRV Analysis Methods, Interpretation of HRV, software’s used for HRV recording, importance of HRV measurement, HRV in varying conditions, drugs etc.
HRV offers a relatively simple, well-tolerated, and inexpensive method for studying physiological and pathophysiological processes in a noninvasive manner. However, there are several important challenges in this area of study. There are a number of confounding variables which contribute to HRV data collection and interpretation open to question. Again, one should not compare one’s HRV with others, since HRV is affected by numerous internal and external factors, namely, age, lifestyle, hormones, body functions etc.

Keywords: Heart rate; Respiratory sinus arrhythmias; Cardiac diseases; Medications

Introduction

Heart rate is mainly determined by pacemaker current generated in the SA node [1]. It is regulated by ANS, which is mediated through nucleus tractus solitaries (NTS) situated in the brainstem (medulla). NTS collects sensory information from chemoreceptors, baroreceptors, muscle afferents, circulating hormones [2] and send autonomic (involuntary) control to heart and blood vessels via sympathetic and parasympathetic nerves. Sympathetic stimulation enhances chronotropic, ionotropic and dromotropic activity via α and β receptor activation whereas, parasympathetic stimulation causes reverse effect on heart via the M2 receptors. Variation in the output of these two branches of the autonomic system produces variability in chronicity of the heart [3,4]. Thus, this variability in heart rate is a physiologic phenomenon and is a reflection of the cardiac modulation by the ANS [5].Lately, prefrontal cortical activities have also been linked to modulate heart rate [6].

So, HRV is a variation in the time interval between heartbeats. In other words, HRV is the time difference between a given heart beat to the mean duration of heartbeat. It is different from Heart beat rate. If heart beat rate is 60 beats per minute, each heart beat may not have precisely occurred in each second. It may be such that one heart beat might have occurred at 960 ms and the other at 1112 ms. Difference of each with the “mean value” say 1000 ms gives HRV of 40 ms and 12 ms respectively for those two beats. HRV, thus, refers to beat-to-beat changes in the heart rate [7].

Other names of HRV are inter-beat intervals, R-R intervals, N-N intervals, heart period variability, RR variability, cycle length variability etc. This variability is perfectly normal and is, infact, desirable. If the heartbeat intervals are constant, HRV is considered to be low; and if the length varies, then HRV is considered to be high [8].

Like all other organs of the body, heart is also susceptible to aging and diseases. These conditions influence the heart rate and also the heart rate variability. This, variation in HRV may point out current disease or impending cardiac and other systemic diseases. Thus, measurement of HRV offers a prognostic plus diagnostic tool in different forms of illnesses [9-13].

Today, HRV has become the subject of active investigation and debate [14,15]. So, this is the authors’ endeavor to summarize an extensive literature review on HRV and its potential uses presented in different electronic publications.

Materials and Methods

Electronic databases Google Scholar, IMSEAR (Index Medicus for South-East Asia Region), Scopemed and MEDLINE/PubMed were extensively explored with terms “HRV” or “Heart Rate Variability” from earliest date (1973) to December of 2016. Articles written in any language especially those published in contemporary years were given priority. For articles published in other languages than English, only abstracts were reviewed.

Discussion

Historical background

In 1733, the Rev. Stephen Hales reported for the first time that beatto- beat heart rate interval and blood pressure measured from arteries vary during the respiratory cycle [16]. After 100 years, Carl Ludwig used kymograph to record the first periodic changes in the amplitude and time of the pressure waves which varied along with respiration. He observed that pulse interval elevated during inspiration and decreased during expiration, which was the first documented report which later was known as the Respiratory Sinus Arrhythmia (RSA) [17].

With advent ECG, it became possible to detect beat-to-beat variations in the cardiac rhythm. The clinical importance of HRV was identified in 1963, when investigators found that just earlier to fetal death, variations in beat-to-beat length were detectable even prior to the variations in the heart rate itself. Again, HRV was reported to have prognostic value in 1987 since decreased HRV was correlated with decreased survival in myocardial infarction [18].

HRV analysis methods

There are different ways by which HRV can be analyzed. More commonly it can be measured in two ways i.e. as the alterations in time between two serial R waves on an ECG (‘Time domain measures’) or as breaking down of the wave form of ECG-RR intervals into frequency power bands using spectral analysis [19,20].

Time-domain: SDNN (standard deviation of RR intervals), is often calculated in a 24-h duration. It represents total alteration.

• SDANN (standard deviation of the average RR intervals), is calculated usually for 5 min.

• RMSSD (Root Mean Square of Successive Differences), the square root of the mean of the squares of the successive differences between adjacent RRs.

• SDSD (Standard Deviation of Successive Differences), measures the standard deviation of the successive differences between adjacent RRs.

• NN50, the number of pairs of successive RRs that differ by >50 ms.

• pNN50, the proportion of NN50 divided by total number of RR

• NN20, the number of pairs of successive RRs that differ by >20 ms.

• pNN20, the proportion of NN20 divided by total number of RRs [4].

Among them, the most frequently used time-domain measures are average SDNN and RMSSD. All time domain measure could be affected by artifacts and outliers, therefore, these should be carefully eliminated. This also is derived by geometric or graphic methods, plotting triangular index. But, this method is highly not affected by artifacts and ectopic beats as these are left out of the triangle and also requires reasonable number of NN intervals to generate it. Time domain measures are simple to compute but lack the ability to discriminate between different components of ANS on HRV.

Frequency-domain: Frequency domain measures use bands of frequency and then count number of RR intervals that match the bands. For 2–5 min recording, three main peaks are recognized i.e. Very low frequency (VLF) <0.04 Hz, Low frequency (LF), 0.04-0.15 Hz, and High frequency (HF) 0.15-0.4 Hz. A fourth peak, Ultra-low frequency (ULF) 0.003-0.04 Hz, is generated if measured for 24 h. It was the Task Force analysis which split heart rhythm oscillations into those four frequency bands. It also stated that the analysis must be done for five minute segments [21].

Power spectral density (PSD) is another method of analysis which gives fundamental information on the power distribution. Discrete Fourier transform is one of the most commonly used PSD methods whereas, Lomb–Scargle (LS) periodogram is one of the most appropriate PSD estimation method [22].

Non-linear methods: There is increasing evidence to suggest that the heart is not a periodic oscillator under normal physiologic conditions [23] and the commonly employed moment statistics of HRV may not be able to detect subtle, but important changes in HR in time series. Therefore, several new analysis method of HR behavior, motivated by nonlinear dynamics and chaos theory, have been developed to quantify the dynamics of HR fluctuations [24,25]. In other words, the cardiovascular system is very complex to be of a linear nature, so the only way one can comprehend HRV is by using nonlinear methods as they offer more valid interpretations of ANS activity and is less sensitive to confounders [19].

The Poincaré plot is the most commonly used non-linear method of analyzing HRV. Each data point represents a pair of consecutive beats, the x-axis represents the current NN interval, while the y-axis represents the previous NN interval [19].

Interpretation of HRV

HRV is actually an umbrella term for many different calculations and analysis methods. While there is wide agreement about the interpretation of these measures, there remains some debate about the precise implications of each parameter [26].

Time domain: The SDNN is predominantly indicates sympathetic activity while the RMSSD and pNN50 are indicative of vagal action [13,27].

Frequency domain measures: HF (0.15-0.40 Hz) is considered to reflect the activity of the parasympathetic system (vagus nerve). HF is increased by respiration, cold provocation of the face, and rotation [28]. In the past, LF was thought to reflect sympathetic activity but today, not much is known regarding LF input activity. However, in the scientific community it is now widely accepted that it displays admixture of both divisions of ANS [29]. LF increases during standing, 90° tilt, mental stress, and moderate exercise [14]. LF/HF ratio is considered to show sympathovagal balance [21]. VLF reflects a host of factors: the inputs from chemoreceptors, sympathetic nervous system, thermoreceptors, the renin-angiotensin system and still others [30]. Total power (TP) is a broad measure of autonomic activity. So, for the abnormal cases, this ratio either decreases or increases from the normal range [20,31,32].

Nonlinear method: In Poincare method, the plot is adjusted with an ellipse; three important parameters then define the plot. These are the length of the semi-minor axis of the ellipse SD1, the length of the semimajor axis of the ellipse SD2, and their ratio of SD1 to SD2. The parameter SD1 is the standard of deviation of instantaneous beat-tobeat HRV and it is the measure of short term variability of HR. It is mainly influenced by parasympathetic regulation on the heart. Other parameter SD2 is the measure of long-term variability and is modulated by both parasympathetic and sympathetic nervous system. SD1/SD2 represents the ratio of short term and long-term variability [33].

Software

Methods used to detect heart-beats include: blood pressure, ECG, ballistocardiograms, and the pulse wave signal derived from a photoplethysmograph. Since HRV focuses on the imperceptible changes between each heartbeat (in milliseconds), it is much more complex and requires higher degree of accuracy than heart rate. In addition, it is cumbersome and tedious to study and pinpoint defects in a huge volume of data collected over several hours. Therefore, computer-based tools for in-depth study of data over long intervals have become very useful in diagnostics [34]. Softwares used to analyze HRV, though, not inclusive of all are:

• OleaSense

• Nerveexpress

• Kubios HRV

• Ithlete HRV

• Intellewave

• HRVAS–MATLAB

• HRV Analysis

• Firstbeat sports

• Elite HRV research and personal

• ANSLAB–MATLAB-based program

Acknowledge: Thus, today, HRV measurement is easy to perform, noninvasive, and have good reproducibility, if used under standardized conditions. Softwares are capable of helping investigators to manage artifacts [35,36].

Duration

Classically, it takes ten minutes to get an accurate short-term HRV measure (that consists of 5 min of stabilization and next 5 min of recording), but today with advancement in research and technology, ultra-short recordings of just one minute are also possible [37].

Position

Ultra-short HRV recordings can be recorded in following positions: supine, seated and standing [14].

Why is HRV Important?

HRV is a tool that indicates both branches of ANS are working especially the parasympathetic branch. Parasympathetic activity decreases the intrinsic heart rate thus provides more space for variability between consecutive heartbeats. Whereas, sympathetic activity accelerates the heart rate and leaves less space for variability between the successive heart-beats. So, HRV reflects the recovery and readiness of the body [14].

In 1994, Framingham Heart Study detected increased HRV, as the only frequent factor, in all healthy people. So, HRV testing was postulated to serve as a prognostic indicator of aging, fitness levels, all cardiac conditions, chronic disease conditions and stress levels related to job/work, making complex decisions, public speaking, and performing tests/exams etc. And also, it is capable to detect autonomic dysfunction as well [14].

So, when the vagal input is active and the sympathetic branch is passive, the heart rate slows down whereas, the HRV becomes higher. This increased HRV signifies an affirmative adaptation or better recovery. As a rule of thumb, it can be said that the higher the person’s HRV, the better is the recovery or the fitter the person is are and vice versa. For these reasons, lately it has caught the minds of athletes, coaches and the common-men [8].

HRV Analysis in Different Conditions

As aforementioned, HRV is affected by degree of sympathetic and parasympathetic outflow. The activity of the ANS is sensitive to nonmodifiable factors like age and gender [38,39] as well as modifiable lifestyle factors like physical activity, smoking, pollution, alcohol consumption [12,40,41], food and water intake [42], circadian rhythm [43,44], heart rate [45,46], blood pressure [47] and several medications [4850]. Physiological factors such as baroreflex, chemoreflex, thermoregulation, sleep-wake cycle, meals, physical activity, hormones and stress are also found to affect the ANS activity. Lately, peripheral and the central nervous systems are also found to play a major role in affecting the HRV [51]. Thus, even the healthy individuals show haphazard HRV dynamics. While those suffering from diseases show decreased levels of fluctuation.

Respiratory sinus arrhythmias (RSA)

Normal resting rhythmicity of the heart is highly variable rather than being monotonously regular. The ECG of a healthy person under resting condition shows periodic variation in RR interval with respiration which is known as RSA. RSA oscillates with the phase of respiration. Cardio-acceleration is observed during inhalation and cardio-deceleration during exhalation. During inspiration, the cardiovascular center constrains the parasympathetic outflow thus quickening the heart rate. Conversely, during exhalation, it reestablishes the parasympathetic outflow resulting in delaying the heart rate by acetylcholine release [52].

Despite many years of investigations, the contribution of the central and peripheral mechanisms together with its functional significance has still remained a subject of considerable debate. Evidences derived from experiments in canines have suggested that the Bainbridge reflex, an autonomous pulmonary reflex, may be involved. Cardiac reflexes and respiratory activities like rib cage movements may also have contributed to RSA [53].

Age, gender and circadian rhythm

It is proved that, HRV depends on age and sex. Bonnemeir et al. [54] proved attenuation of RSA with advancing age [55]. Aging also results in loss CNS neurons causing degradation of signal transmission and reduction in regulatory capacity [56]. Henceforth, HRV declines with the aging because of continuous wear and tear [31]. Whereas, regular physical exercise delays the aging process by increasing HRV by enhancing vagal tone [57-59]. In fetus, HRV increases with gestational age and is high during early postnatal life [60].

It was also found that HRV is usually more in the case of females than men. Hence, compared to men, women are at lower risk of coronary heart disease [61]. There also seemed to be a significant difference in HRV between day and night hours [62].

Physical activity

Regular physical exercise modifies cardiac autonomic control. Regularly exercising individuals have a disorder that is known as 'athlete bradycardia' and generally have greater HRV compared to sedentary ones [63]. In another study, it was observed that HRVguided training group could run better than the other group which was pre-planned [64].

In one experiment, intense training period increased HRV but later the variable became stagnant and also decreased subsequently during an overload training phase. However, after a two-week recovery period, HRV bounced back and was even more than the baseline value [65]. Thus, results from multiple studies [66] concludes that HRV distinctively analyze stress that the body undergoes during training and to increase insight into physiological recovery after training. HRV, therefore, is becoming a useful tool for tracking training adaptation or maladaptation of athletes. It also sets an optimal training load leading to improved performances [67]. Thus, the HRV in physical exercise has imparted a significant contribution in sports physiology [8]. Exercise has shown promise, but there is varying efficacy and differences in effect between resistance exercise and aerobic exercise [68].

Sleep

It was proved that during deep sleep HRV decreases in healthy subjects [69]. Compared to stages 2 and 4 Non-REM sleep, the total power is higher in REM sleep and the value slowly increases during each REM cycle [70]. The LF component was higher in REM sleep than in stages 2 and stage 4 Non-REM sleeps. In normal sleep, parasympathetic activity is more around sleep onset and also during sleep stages I, II, III and IV. Conversely, as stated above, the sympathovagal balance is reversed during rapid eye movement (REM) sleep [70,71].

The VLF component reflects slow regulatory mechanisms, e.g., the renin-angiotensin system, thermoregulation, is higher in REM sleep than in stage 2 and stage 4 of Non-REM sleep. Again, Gates et al. suggested that, long-lasting alterations existed in autonomic function in snoring subjects [72-74].

The variations in HRV also relates to poor sleep quality as measured by either Pittsburgh Sleep Quality Index or the Epworth Sleepiness Scale) but not with the measures of depression like Beck Depression Inventory and Hamilton Depression Rating Scale. Hence, it can be concluded that insomnia causes adverse changes in autonomic function, irrespective of depression [75].

Infant and sleep

Investigations in the fetus and newborn have revealed that during n REM sleep long-term variability increases whereas, short-term variability decreases compared to Non REM sleep [60,76]. These differences between REM and Non-REM sleep are due to a shift from higher sympathetic tone while REM sleep to a higher vagal tone during non-REM sleeps [77]. In infants and children, the ratio between LF and HF powers changes with the various sleep stages (p<0.02 in infants; p<0.01 in children): it decreases during deep sleep and increases during REM sleep. Research has found high HF power in children than in infants [78].

SIDS

High-frequency HRV in infants is altered with known risk factors for SIDS including prematurity, prenatal exposures, such as smoking, and environmental exposures, such as prone sleeping [79].

Smoking

HRV analysis Studies have shown that smokers have more sympathetic activity than vagal activity. Also, it was proved in heavy smokers that vagal modulation of the heart is blunted, particularly during a parasympathetic maneuver [80]. Thus, smoking reduces the HRV [80,81]. Recently Zeskind and Gingras have shown that cigarette exposed fetuses have lower HRV and disrupted temporal organization of autonomic control before delivery and postnatal adaptation occur. They also found that possible nicotine withdrawal may have shown the differences in infant neurobehavioral function [82].

Alcohol

HRV decreases in acute alcohol intake. It suggests sympathetic activation together with parasympathetic withdrawal [83]. ECG indices of vagal activity have been reported to have significantly lower indices of cardiac vagal nerve activity than normal volunteers in acute alcoholic subjects [84,85]. In addition, Malpas et al. have shown vagal neuropathy in chronic alcohol dependent men [84].

Infection

HRV has been found to change in illness, and the intensity of this change is prognostic of illness severity. Hence HRV studies may have a role in future diagnosis and management of sepsis along with septic shock [86].

Pontet and colleagues used Fourier spectral analysis as an early marker of MODS in septic patients [87]. In few studies, it is documented that abnormal HRV with decreased variability and temporary decelerations precedes neonatal or infant sepsis. HRV is detected about a day earlier than the clinical diagnosis of sepsis with markers like tachycardia, fever or positive cultures [88,89].

The expected consequence correlates positively with Sequential Organ Failure Assessment (SOFA) score and Acute Physiological and Chronic Health Evaluation (APACHE) II scores [90-93].

Compared with healthy infants, infants who experience sepsis, have similar sample asymmetry in health, and elevated values before sepsis and SIRS (p=0.002) [94].

Blood pressure

HRV is significantly reduced in patients with left ventricular Hypertrophy (LVH) secondary to hypertension or aortic valve disease. This reduction in baroreflex sensitivity is correlated with cardiac LVH. Hypertensive has decreased baroreflexes and HRV [95].

Myocardial infarction

A predominance of sympathetic activity and reduction in parasympathetic cardiac control is seen in MI patients [96]. The degree of RSA shows a linear relation with parasympathetic cardiac control and thus can be used as a prognostic tool in patients, who have had a MI. [97,98].

It was shown that, HRV decreases with recent MI [99]. Despite beneficial effects on clinical variables, exercise training, in one study, did not markedly alter HRV indexes in subjects after MI [96].

Two well-known trials, namely the Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) and TRAndolapril Cardiac Evaluation (TRACE) demonstrated that decreased HRV is associated with increased mortality after MI [100,101].

Sudden cardiac death

Patients of sudden cardiac death have lower HRV compared to healthy individuals [102].

Cardiac arrhythmia

Sympathetic activity decreases the fibrillation threshold and predisposes to ventricular fibrillation. Vagal activity increases the threshold and appears to protect against malignant ventricular tachyarrhythmias [103].

Congestive heart failure (CHF)

HRV is depressed in patients with CHF compared to healthy subjects. Among patients with CHF, HRV is further decreased in patients with more advanced New York Heart Association (NYHA) class, lower ejection fraction and in those with diabetes, hypertension or Ventricular Tachycardia on Holter monitoring [104].

Other cardiac diseases

Left Branch Bundle Block, Congestive Heart Block, Sick Sinus Syndrome and Premature Ventricular Contraction [105] on contrary have shown high HRV measures.

Thus, HRV is strongly associated with arrhythmias and all causes of cardiovascular mortality [103,106]. Hence, HRV can detect patients at high risk for future cardiovascular events [107].

Fetal heart rate monitoring

Fetal heart rate monitoring has now become the standard of care during pregnancy/parturition and has complemented immensely in reducing fetal distress related morbidity [108].

Liver cirrhosis

Liver cirrhosis decreases HRV. HRV also prognosticates and predicts mortality. Decline in HRV parameters causes rise in plasma pro-inflammatory cytokine levels. It also causes impaired neurocognitive function [109].

Thyroid

Hypothyroidism may result in cardiac autonomic dysfunction. Thus, HRV can be used to monitor cardiovascular-related risk in these patient-populations [110].

Nervous system

Changes in ANS activity have been linked to a variety of mood disorders, including bipolar disorders, depressive disorders, anxiety disorders and schizophrenia [42,111-114]. The significance of HRV analysis in psychiatric disorders arises from the fact that one can easily detect a sympathovagal imbalance (relative cholinergic and adrenergic modulation of HRV) in such pathologies. Also, there are conflicting reports about the HRV and the major depression. It is proved that, in physically healthy depressed adults the HRV does not vary from healthy subjects [115].

Also normal cyclic changes in HR are reduced in the presence of severe brain damage [99,116,117]. Regarding brain damage HRV was less accurate than the Glasgow Coma Scale in predicting outcome. But it was easily accessible and may provide information about the patient’s neurologic status [115].

Again, cardiac vagal tone regulation has also been connected to regulation of emotional reactivity, psychological flexibility, social engagement, and reduced prefrontal cortical activity [118121].

Attention-deficit hyperactivity disorder (ADHD)

Results of study done by Börger et al. indicated that compared to controls ADHD subjects had a greater 0.10-Hz component which was associated with poor test performance over time. Improvements were demonstrated in a study employing coherence training with a group of middle school students with attention-deficit hyperactivity disorder. Improvements were shown in their short-and long-term memory, ability to focus and behaviors at home and school [122].

Post-traumatic stress disorder (PTSD)

In PTSD subjects, HF component of HRV is lessened whereas the LF component is accentuated. A study among recently returning soldiers from Iraq diagnosed with PTSD found that after relatively brief periods of HRV coherence training showed significant amendments in the capability to self-regulate along with significant improvements in a wide range of cognitive functions were found. It correlated with increased cardiac coherence [123].

Unipolar depression

Results from several studies show that ANS dysfunction is one of the markers for depression [124]. Reduction in HRV in depressive disorder may be a biomarker of depression [125]. The lower HRV measures in depressed subjects did not change with positive clinical response to either treatment modality. However, these conclusions await for further confirmation [126].

Messerotti Benvenuti et al. found a significant association between somatic symptoms of depression (using the Beck Depression Inventory II) and reduced HRV, measured by SDNN, NN50 and TP (but not RMSSD) [127]. The evidence for parasympathetic deregulation in depressive disorders was critically assessed by Rottenberg in a metaanalysis of 13 cross-sectional studies. He inferred that low mood contributed a small effect size impact upon vagal control, and it only elucidated about 2% variance, with ‘medium’ effect size (Cohen’s d=0.332) [128]. Whereas, in another study, Kemp et al. performed a meta-analysis of 18 studies in 673 patients with Major depressive disorder and 407 healthy control subjects. They found that those with depression had lower time-domain HRV, greater ‘high-frequency’ power measures and greater Valsalva ratios than controls. Non-linear measures (probably more reliable than linear measures) indicated a negative correlation of depression [10]. It may offer even more specificity for melancholic/somatic subtypes of depressive illness [129] but this requires further confirmation.

Vagal nerve stimulation (VNS) has shown promise as a treatment for severe depressive disorders [130132]. Whereas, Tricyclic antidepressants decreased HRV, while selective serotonin reuptake inhibitors Mirtazapine and Nefazodone, had no effects on HRV [10].

Bipolar disorder

Henry et al. found maniacs showed reduction in SDNN. However, the HF score and LF/HF ratio were higher in them. Again, Timedomain measures of HRV, RMSSD and pNN50, were lower in them [133]. In another study, the manic subjects had lower SDNN, RMSSD, TP, LF and HF measures [134]. The SDNN, TP and LF/HF ratios were significantly lower in the bipolar subjects than controls, and HF power was higher, suggesting a reduction in the sympathovagal ratio [135]. There was negative correlation between the CGI-S score and SDNN, RMSSD, pNN50, LF and HF powers. Interpretation was subsyndromal bipolar depression had reduced HRV [136].

Whereas, after medication, apart from a small decrease in LF/HF ratio with lithium use, there was no notable differences in measures related to mood stabilizer or antipsychotic use. One study showed that HRV measurement could help separation of unipolar with bipolar depression; however it further needs confirmation [137].

Tetraplegia

Tetraplegics have lesion in upper cervical spinal cord. Patients having complete upper cervical cord lesions, however, still have undamaged vagal efferent pathways to the SA node. Despite these, an LF portion is often found in HRV and also there is arterial pressure variability [21].

Cardiac transplantation

Ramaekers et al. performed time and frequency domain analysis of Holter recordings in more than hundred heart transplants and four heart-lung transplant recipients. They found HF component evolved overtime attuned with a physiological phenomenon indicating slow vagal reinnervation of the SA [138].

ANS dysfunction

Increased SNS or diminished PNS activity results in cardioacceleration. Conversely, a low SNS activity or a high PNS activity causes cardio-deceleration. HRV is a useful signal for understanding the status of the ANS. The normal variability in HR is due to autonomic neural control circulatory system [139]. It is a valuable tool to investigate the sympathetic and parasympathetic function of the ANS. Thus, this should enable protective interpolation at an initial stage when it is beneficial [140].

Diabetes

Diabetes may result in autonomic dysfunction. Traditional measures are able to document the presence of neuropathy, in general only when there are severe symptoms [141]. In studies comparing cardiac autonomic function tests and HRV indices in diabetic patients without abnormal function tests, HRV was lowered [142]. It was again verified that cardiac (parasympathetic) autonomic activity was diminished in diabetic patients before clinical symptoms of neuropathy become evident [143,144]. The decreased beat-to-beat variability during deep breathing in diabetic neuropathy has also reported [145].

Renal failure

In chronic renal failure patients, the mean power in the LF band was higher and lower in the HF bands than the corresponding values in the healthy subjects [146].

Metabolic syndrome

Vagal-mediated HRV indices were reversely linked with many risk factors for Type 2 diabetes namely, insulin resistance, glucose intolerance, hypertension, central obesity and dyslipidemia [147].

Drugs/Medication Effects in HRV

Beta-Adrenergic Blockade or Stimulation

Even in those without elevated blood pressure, the beta-adrenergic blocker, atenolol, appears to accentuate vagally mediated rapid oscillations in Heart Rate [148]. Guzzetti et al. [149] studied the effect of atenolol in patients with essential hypertension. They found not only an increase in HF fluctuations, but also a decrease in the sympathetically mediated LF oscillations. This decrease in sympathetic activity was also noticed in post infarction patients using Metoprolol [150] and in cardiac failure patients using Acebutolol [151]. Thus, beta-blockers are able to restore the sympathetic–parasympathetic balance in cardiovascular disease.

Again, the unexpected observation that prior to MI, beta-blockade enhances HRV only in those animals which are destined to be at low risk of lethal arrhythmias after MI. This can advocate new approaches to post-MI risk stratification [152].

Eryonucu et al. [153] explored the effects of β2- adrenergic agonist on HRV in asthmatics by using frequency domain measures. The LF and LF/HF ratio were high and TP low at five, ten, fifteen and twenty min after salbutamol and the Terbutaline inhalation. HF, however, did not vary much after those drugs inhalation.

Antiarrhythmic Drugs

Flecainide and Propafenone but not Amiodarone were documented to lessen time domain of HRV in those with chronic ventricular arrhythmia [154]. Whereas another study showed that Propafenone decreased total HRV and LF greater than HF [155]. Another study with larger sample size established that Flecainide, also Encainide and Moricizine, reduced HRV in post-MI patients but there was no correlation between the HRV and mortality during follow-up [155].

Scopolamine

Atropine and scopolamine produce a unexpected rise in parasympathetic effects in the heart. HRV varies widely across and within individuals. This, however, indicates that even for parasympathetic activity to the heart, HRV may still be a limited marker [156].

Lithium and Antipsychotics

Henry et al. found that mood stabilizer or antipsychotic use had no significant effect upon HRV measures [114]. Agelink et al. explored the effects of Amisulpride, Olanzapine, Sertindole and Clozapine on HRV schizophrenics. They concluded that only clozapine decreased RMSSD, though the variations in all other parameters were very large [157].

Iwamoto et al. measured the effects of Chlorpromazine and Mepromazine in HRV of 211 schizophrenics and 44 controls. They reported that the LF and HF powers were lower, but LF/HF ratios the same in the schizophrenia subjects. This confirmed a decrease in overall autonomic activity without an alteration in sympatho-vagal balance. A negative correlation of antipsychotic dose effect upon LF and HF power were noted. The muscarinic property of Mepromazine and Chlorpromazine may have caused this [158].

Linder et al., in a carefully executed study, measured HRV parameters in 55 young, predominantly female patients (mean age=33 ± 7 years, 67% female) suffering from bipolar disorders (I and II), who were taking antipsychotic medications. Recent use of atypical antipsychotics was linked with a decrease in SDNN and RMSSD and strongly concerned with dopamine receptor 2 affinity (paradoxically, given high affinity in first generation antipsychotics). However, extended use of antipsychotics (up to 5 years) and the use of Lithium or anticholinergic medications were not associated with significantly reduced HRV measures [159].

Antidepressants

Davidson et al. found that venlafaxine is associated with a greater fall in HRV indices than Paroxetine [160] while Van Zyl et al. found Tricyclic antidepressants are associated with reductions in HRV indices over short recordings (2–40 min) but not long recordings (24 h) [161]. Kemp et al. had found similar HRV trends in Tricyclic antidepressants, while sertraline, mirtazapine and Nefazodone had no measurable effects [162]. Again, Udupa et al., using brief ECG recordings, found time and frequency domains reduced with Tricyclic antidepressants (n=32) and not with SSRIs (n=32).

Agelink et al. demonstrated Reboxetine does not cause any significant changes in vagally mediated HRV indices [163], while Siepmann et al. found that Moclobemide altered measures of HRV. Then, Kemp et al. reported that Escitalopram given to forty-four controls of more than 25 years in age had increased HF component of HRV, both at rest and during psychological stress [164].

Chappell et al. carried out a randomized, controlled, single-blind, cross-over study using a placebo, Duloxetine or Escitalopram. It revealed that time-based and frequency-based HRV measures were not significantly different [165]. Terhardt et al. experimented with Venlafaxine and Mirtazapine. They found that HRV measures declined during treatment with either medication, while heart rate increased [166].

In a meta-analysis of a very large cohort, Kemp et al. found that a large range of antidepressant medications (tricyclic antidepressants, serotonin and noradrenaline reuptake inhibitors, selective serotonin reuptake inhibitor and other unspecified antidepressants significantly decreased RMSSD and HF [50].

Benzodiazepines

Khaspekova et al. found improvement of HRV in a study of Clonazepam in the management of paroxysmal atrial fibrillation. In another study by Komatsu et al. on Midazolam found reduced LF elements of HRV and increased HF elements, during anesthesia [167].

Anticonvulsants

Lotufo et al., in their meta-analysis, reported less effect of anticonvulsants on HRV [157]. Again, Stefani et al. detected if anticonvulsants was withdrawn, there was no variations in HRV [168].

Thrombolysis

Thrombolysis affected pNN50 as reported in 95 acute MI patients. HRV was greater after ninety min of thrombolysis [169].

Playing Wind Instruments

In those playing Native American flutes, it was observed that both low and high-pitched flutes increase HRV [170].

Biofeedback

HRV biofeedback has shown some positive effects upon HRV [171], Acupuncture has shown encouraging but constraint results, while the benefits from Yoga is largely uncertain [172].

Resonant breathing biofeedback identifies and regulates involuntary HRV. A randomized controlled trial by Sutarto et al. assessed this effect among manufacturing operators having depression and anxiety. They found stress significantly decreased HRV [173].

Therapeutic interventions to enhance HRV

HRV techniques have been demonstrated to be important in treating cardiovascular diseases, Alzheimer, chronic migraines, leukemia, renal failure, epilepsy, obstructive sleep apnea. Regular endurance exercise tends to increase HRV. Interestingly, HRV is lowered if one is about to get unwell even before the appearance of the symptoms.

Limitation

A number of confounding variables contribute to HRV data collection and interpretation. Designing research methodology to minimize the confounding variables associated is the need of the hour.

Careful attention to the management of confounding variables through more substantial sample sizes, careful subject selection (particularly subjects not taking relevant medications); use of nonlinear measures, appropriate statistical analyses would facilitate our knowledge in different conditions.

In HRV, there is no normal range value as in other investigations which can directly point/throw light about the current health status of the subject. It is based on comparison between a control and a diseased person or same person’s before and after conditions. And another thing is one should not compare one’s HRV with other human being, since HRV gets influenced by a numerous factor such as hormones, aging overall body physiology, lifestyles etc. Therefore, one should look and compare on one’s own HRV along with the direction it is heading for.

Conclusion

HRV offers a relatively simple, well-tolerated and inexpensive method for studying physiological and pathophysiological processes in a noninvasive manner. It is easy to perform, have relatively good reproducibility and provide prognostic information on patients with heart disease. Thus, HRV has prognostic, diagnostic and therapeutic implications.

Attraction towards HRV in scientific community is flourishing every year as technology is growing. Nowadays, many HRV tracking Apps are available which monitor HRV in a daily basis.

References

  1. Campbell GD, Edwards FR, Hirst GD, O’Shea (1989) JE Effects of vagal stimulation and applied acetylcholine on pacemaker potentials in the guinea-pig heart. J Physiol 415: 57–68.
  2. Hill LK, Hu DD, Koenig J, Sollers JJ, Kapuku G, et al. (2015) Ethnic Differences in Resting Heart Rate Variability. Psychosom Med 77: 16–25.
  3. (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17: 354–381.
  4. (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation  93: 1043–1065.
  5. Saul J (1990) Beat-To-Beat Variations of Heart Rate Reflect Modulation of Cardiac Autonomic Outflow. Physiology 5: 32–37.
  6. Napadow V, Dhond R, Conti G, Makris N, Brown EN, et al. (2008) Brain correlates of autonomic modulation: combining heart rate variability with fMRI. Neuroimage 42: 169–177.
  7. Dong JG (2016) The role of heart rate variability in sports physiology. Exp Ther Med 11:1531–1536.
  8. Stapelberg NJ, Hamilton-Craig I, Neumann DL, Shum DH, McConnell H (2012) Mind and heart: Heart rate variability in major depressive disorder and coronary heart disease - a review and recommendations. Aust N Z J Psychiatry  46: 946–957.
  9. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, et al. (2010) Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis. Biol Psychiatry  67:1067–1074.
  10. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, et al. (2000) Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 62: 639–647.
  11. Brunoni AR, Kemp AH, Dantas EM, Goulart AC, Nunes MA, et al. (2013) Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study. Int J Neuropsychopharmacol 16: 1937–1949.
  12. Heathers JAJ (2014) Everything Hertz: methodological issues in short-term frequency-domain HRV. Front. Physiol 5: 177.
  13. (1996) Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Eur Heart J 17: 354–381.  
  14. Parati G, Mancia G, Rienzo M Di, Castiglioni P (1985) Point:Counterpoint: Cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol 101: 676–682.
  15. Hales S (2000) Foundations of anesthesiology. An account of some hydraulic and hydrostatical experiments made on the blood and blood-vessels of animals. J Clin Monit Comput 16: 45–47.
  16. Billman GE (2011) Heart rate variability - a historical perspective. Front Physiol 2:86.
  17. Compostella L, Lakusic N, Compostella C, Truong LVS, Iliceto S, et al. (2017) Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization? World J Cardiol 26: 27-38.
  18. Voss A, Baier V, Schulz S, Bar K (2006) Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. Bipolar Disord 8: 441–452.
  19. Acharya U R, Kannathal N, Sing OW, Ping LY, Chua T (2004) Heart rate analysis in normal subjects of various age groups. Biomed Eng 3: 24.
  20. (1996) Electrophysiology TF of the ES of C the NAS of P. Heart Rate Variability. Circulation 93: 1043-1065.
  21. İşler Y, Kuntalp M (2007) Combining classical HRV indices with wavelet entropy measures improves to performance in diagnosing congestive heart failure. Comput Biol Med 37: 1502–1510.
  22. Goldberger AL, West BJ (1987) Applications of nonlinear dynamics to clinical cardiology. Ann N Y Acad Sci 504: 195–213.
  23. Pincus SM (1991) Approximate entropy as a measure of system complexity. Proc Natl Acad Sci U S A 88: 2297–301.
  24. Akay M (2001) IEEE Engineering in Medicine and Biology Society. Nonlinear biomedical signal processing. Dynamic analysis and modeling IEEE Press 2.
  25. Quintana DS, Heathers JAJ (2014) Considerations in the assessment of heart rate variability in biobehavioral research. Front Psychol 5: 805.
  26. Chandran V, Elgar SL (1993) Pattern recognition using invariants defined from higher order spectra - one-dimensional inputs. IEEE Trans Signal Process 41: 205–212.
  27. Billman GE (2013) The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 4: 26.
  28. Just A, Kirchheim HR, Ehmke H (1998) Buffering of blood pressure variability by the renin-angiotensin system in the conscious dog. J Physiol 512: 583–593.
  29. Acharya U R, Kannathal N, Krishnan SM (2004) Comprehensive analysis of cardiac health using heart rate signals. Physiol Meas 25: 1139–1151.
  30. Kaplan DT, Cohen RJ (1990) Searching for chaos in fibrillation. Ann N Y Acad Sci 591: 367–374.
  31. Shaffer F, Ginsberg JP (2017) An Overview of Heart Rate Variability Metrics and Norms. Front public Heal 5: 258.
  32. Citi L, Brown EN, Barbieri R (2012) A Real-Time Automated Point-Process Method for the Detection and Correction of Erroneous and Ectopic Heartbeats. IEEE Trans Biomed Eng 59: 2828–2837.
  33. Ge D, Srinivasan N, Krishnan SM (2002) Cardiac arrhythmia classification using autoregressive modeling. Biomed Eng Online 1: 5.
  34. Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, et al. (1991) Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol 68: 626–630.
  35. Munoz ML, van Roon A, Riese H, Thio C, Oostenbroek E, et al. (2015) Validity of (Ultra-)Short Recordings for Heart Rate Variability Measurements. PLoS One 10: e0138921.
  36. Thayer JF, Smith M, Rossy LA, Sollers JJ, Friedman BH (1998) Heart period variability and depressive symptoms: gender differences. Biol Psychiatry 44: 304–306.
  37. Voss A, Schroeder R, Fischer C, Heitmann A, Peters A, et al. (2013) Influence of age and gender on complexity measures for short term heart rate variability analysis in healthy subjects. Conf. IEEE Eng Med Biol Soc 5574–5577.
  38. Romanowicz M, Schmidt JE, Bostwick JM, Mrazek DA, Karpyak VM (2011) Changes in Heart Rate Variability Associated With Acute Alcohol Consumption: Current Knowledge and Implications for Practice and Research. Alcohol Clin Exp Res 35: 1092–1105.
  39. Sagawa Y, Kondo H, Matsubuchi N, Takemura T, Kanayama H, et al. (2011) Alcohol Has a Dose-Related Effect on Parasympathetic Nerve Activity During Sleep. Alcohol Clin Exp Res 35: 2093–2100.
  40. Alvares GA, Quintana DS, Hickie IB, Guastella AJ (2016) Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. J Psychiatry Neurosci 41: 89–104.
  41. Tobaldini E, Nobili L, Strada S, Casali KR, Braghiroli A, et al. (2013) Heart rate variability in normal and pathological sleep. Front Physiol 4: 294.
  42. Boudreau P, Yeh W-H, Dumont GA, Boivin DB (2013) Circadian Variation of Heart Rate Variability Across Sleep Stages. Sleep 36: 1919–1928.
  43. Sacha J, Pluta W (2008) Alterations of an average heart rate change heart rate variability due to mathematical reasons. Int J Cardiol 128: 444–447.
  44. Billman GE (2013) The effect of heart rate on the heart rate variability response to autonomic interventions. Front Physiol 4: 222.
  45. Stein  PKP, Kleiger  RE (1999) Insights from the Study of Heart Rate Variability. Annu Rev Med Annual Reviews 50: 249–261.
  46. Hanson CS, Outhred T, Brunoni AR, Malhi GS, Kemp AH (2013) The impact of escitalopram on vagally mediated cardiovascular function to stress and the moderating effects of vigorous physical activity: a randomized controlled treatment study in healthy participants. Front Physiol 4: 259.
  47. O’Regan C, Kenny RA, Cronin H, Finucane C, Kearney PM (2015) Antidepressants strongly influence the relationship between depression and heart rate variability: findings from The Irish Longitudinal Study on Ageing (TILDA). Psychol Med 45: 623–636.
  48. Kemp AH, Brunoni AR, Santos IS, Nunes MA, Dantas EM, et al. (2014) Effects of Depression, Anxiety, Comorbidity, and Antidepressants on Resting-State Heart Rate and Its Variability: An ELSA-Brasil Cohort Baseline Study. Am J Psychiatry 171: 1328–1334.
  49. Gang Y, Malik M (2003) Heart rate variability analysis in general medicine. Indian Pacing Electrophysiol J 3: 34-40.
  50. Eckberg DL, Eckberg MJ (1982) Human sinus node responses to repetitive, ramped carotid baroreceptor stimuli. Am J Physiol Circ Physiol 242: H638-644.
  51. Hayano J, Yasuma F, Okada A, Mukai S, Fujinami T (1996) Respiratory sinus arrhythmia. A phenomenon improving pulmonary gas exchange and circulatory efficiency. Circulation 94: 842-847.
  52. Bonnemeier H, Richardt G, Potratz J, Wiegand UKH, Brandes A, et al. (2003) Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol 14: 791-799.
  53. Wilson PW, Evans JC (1993) Coronary artery disease prediction. Am J Hypertens 6: 309S-313S.
  54. Jäncke L, Mérillat S, Liem F, Hänggi J (2015) Brain size, sex, and the aging brain. Hum. Brain Mapp 36: 150-169.
  55. Ogliari G, Mahinrad S, Stott DJ, Jukema JW, Mooijaart SP, et al. (2015) Resting heart rate, heart rate variability and functional decline in old age. CMAJ 187: E442-449.
  56. Ryan SM, Goldberger AL, Pincus SM, Mietus J, Lipsitz LA (1994) Gender- and age-related differences in heart rate dynamics: are women more complex than men? J Am Coll Cardiol 24:1700-1707.
  57. Davy KP, DeSouza CA, Jones PP, Seals DR (1998) Elevated heart rate variability in physically active young and older adult women. Clin Sci (Lond) 94: 579-584.
  58. van Ravenswaaij-Arts CM, Hopman JC, Kollée LA, van Amen JP, Stoelinga GB, et al. (1991) Influences on heart rate variability in spontaneously breathing preterm infants. Early Hum 27: 187-205.
  59. Lipsitz LA, Mietus J, Moody GB, Goldberger AL (1990) Spectral characteristics of heart rate variability before and during postural tilt. Relations to aging and risk of syncope. Circulation 81: 1803-1810.
  60. Boudreau P, Yeh WH, Dumont GA, Boivin DB (2012) A Circadian Rhythm in Heart Rate Variability Contributes to the Increased Cardiac Sympathovagal Response to Awakening in the Morning. Chronobiol 29: 757-768.
  61. Dolezal BA, Chudzynski J, Dickerson D, Mooney L, Rawson RA, et al. (2014) Exercise training improves heart rate variability after methamphetamine dependency. Med Sci Sports 46: 1057-1066.
  62. Kiviniemi AM, Hautala AJ, Kinnunen H, Tulppo MP (2007) Endurance training guided individually by daily heart rate variability measurements. Eur J Appl Physiol 101: 743-751.
  63. Pichot V, Busso T, Roche F, Garet M, Costes F, et al. (2002) Autonomic adaptations to intensive and overload training periods: a laboratory study. Med Sci Sports Exerc 34: 1660-1666.
  64. Amano M, Kanda T, Ue H, Moritani T (2001) Exercise training and autonomic nervous system activity in obese individuals. Med Sci Sports Exerc 33: 1287-1291.
  65. Aubert AE, Seps B, Beckers F (2003) Heart rate variability in athletes. Sports Med 33: 889-919.
  66. Kingsley JD, Figueroa A (2016) Acute and training effects of resistance exercise on heart rate variability. Clin Physiol Funct Imaging 36: 179-187.
  67. Elsenbruch S, Harnish MJ, Orr WC (1999) Heart rate variability during waking and sleep in healthy males and females. Sleep 22: 1067-1071.
  68. Busek P, Vanková J, Opavský J, Salinger J, Nevsímalová S (2005) Spectral analysis of the heart rate variability in sleep. Physiol. Res 54: 369-376.
  69. Chouchou F, Desseilles M (2014) Heart rate variability: a tool to explore the sleeping brain? Front Neurosci 8: 402.
  70. Cabiddu R, Cerutti S, Viardot G, Werner S, Bianchi AM (2012) Modulation of the Sympatho-Vagal Balance during Sleep: Frequency Domain Study of Heart Rate Variability and Respiration. Front Physiol 3: 45.
  71. Bianchi AM, Mendez MO (2013) Methods for heart rate variability analysis during sleep. Conf IEEE Eng Med Biol Soc 2013: 6579-6582.
  72. Gates GJ, Mateika SE, Mateika JH (2005) Heart rate variability in non-apneic snorers and controls before and after continuous positive airway pressure. BMC Pulm 5: 9.
  73. Mariani S, Migliorini M, Tacchino G, Gentili C, Bertschy G, et al (2012) Clinical state assessment in bipolar patients by means of HRV features obtained with a sensorized T-shirt. Conf IEEE Eng Med Biol Soc 2012: 2240-3.
  74. Rother M, Zwiener U, Witte H, Eiselt M, Frenzel J (1988) Objective characterization and differentiation of sleep states in healthy newborns and newborns-at-risk by spectral analysis of heart rate and respiration rhythms. Acta Physiol Hung 71: 383-393.
  75. van Geijn HP, Jongsma HW, de Haan J, Eskes TK, Prechtl HF (1980) Heart rate as an indicator of the behavioral state. Studies in the newborn infant and prospects for fetal heart rate monitoring. Am J Obstet Gynecol 136: 1061-1066.
  76. Villa MP, Calcagnini G, Pagani J, Paggi B, Massa F, et al. (2000) Effects of sleep stage and age on short-term heart rate variability during sleep in healthy infants and children. Chest 117: 460-466.
  77. Sahni R, Fifer WP, Myers MM (2007) Identifying infants at risk for sudden infant death syndrome. Curr Opin Pediatr 19: 145-149.
  78. Barutcu I, Esen AM, Kaya D, Turkmen M, Karakaya O, et al. Cigarette Smoking and Heart Rate Variability: Dynamic Influence of Parasympathetic and Sympathetic Maneuvers. Ann Noninvasive Electrocardiol 10: 324-329.
  79. Dinas PC, Koutedakis Y, Flouris AD (2013) Effects of active and passive tobacco cigarette smoking on heart rate variability. Int J Cardiol 163: 109-115.
  80. Zeskind PS, Gingras JL (2006) Maternal Cigarette-Smoking During Pregnancy Disrupts Rhythms in Fetal Heart Rate. J Pediatr Psychol 31: 5-14.
  81. Weise F, Krell D, Brinkhoff N (1986) Acute alcohol ingestion reduces heart rate variability. Drug Alcohol Depend 17: 89-91.
  82. Malpas SC, Whiteside EA, Maling TJ (1991) Heart rate variability and cardiac autonomic function in men with chronic alcohol dependence. Br Heart J 65: 84-88.
  83.  Rossinen J, Viitasalo M, Partanen J, Koskinen P, Kupari M, et al. (1997) Effects of acute alcohol ingestion on heart rate variability in patients with documented coronary artery disease and stable angina pectoris. Am J Cardiol 79: 487-491.
  84. Ahmad S, Tejuja A, Newman KD, Zarychanski R, Seely AJ (2009) Clinical review: A review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care 13: 232.
  85. Pontet J, Contreras P, Curbelo A, Medina J, Noveri S, et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care 18: 156-163.
  86. Griffin MP, Lake DE, Moorman JR (2005) Heart Rate Characteristics and Laboratory Tests in Neonatal Sepsis . Pediatrics 115: 937-941.
  87. Griffin MP, Moorman JR (2001) Toward the early diagnosis of neonatal sepsis and sepsis-like illness using novel heart rate analysis. Pediatrics  107: 97-104.
  88. Yien HW, Hseu SS, Lee LC, Kuo TB, Lee TY, et al. (1997) Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for the prediction of patient outcome in the intensive care unit. Crit Care Med 25: 258-266.
  89. Soriano F, Nogueira A, Cappi S, Lins M, Hoshino W, et al. (2004) Heart dysfunction and heart rate variability prognoses in sepsis. Crit Care 8:P75.
  90. Garrard CS, Kontoyannis DA, Piepoli M (1993) Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res 3:5–13.
  91. Piepoli M, Garrard CS, Kontoyannis DA, Bernardi L (1995)  Autonomic control of the heart and peripheral vessels in human septic shock. Intensive Care Med 21: 112–119.
  92. Kovatchev BP, Farhy LS, Cao H, Griffin MP, Lake DE, et al. (2003) Sample Asymmetry Analysis of Heart Rate Characteristics with Application to Neonatal Sepsis and Systemic Inflammatory Response Syndrome. Pediatr Res 54: 892–898.
  93. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, et al. (2003)  Hypertension, Blood Pressure, and Heart Rate Variability: The Atherosclerosis Risk in Communities (ARIC) Study. Hypertension 42: 1106–1111.
  94. Rothschild M, Rothschild A, Pfeifer M (1988) Temporary decrease in cardiac parasympathetic tone after acute myocardial infarction. Am J Cardiol 62: 637–639.
  95. Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482–492.
  96. Katona PG, Jih F (1975) Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J. Appl Physiol 39: 801–805.
  97. Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, et al. (2005) Low Heart Rate Variability and the Effect of Depression on Post–Myocardial Infarction Mortality. Arch Intern Med 165:1486.
  98. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study Group. Am J Cardiol (1994) 73: 44C–50C.
  99. Schwartz PJ, La Rovere MT (1998) ATRAMI: a mark in the quest for the prognostic value of autonomic markers. Autonomic Tone and Reflexes After Myocardial Infarction. Eur Heart J 19: 1593–1595.
  100. Mølgaard H, Sørensen KE, Bjerregaard P (1991) Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res 1: 233–237.
  101. Schwartz PJ, La Rovere MT, Vanoli E (1992) Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85: I77-191.
  102. Musialik-Łydka A, Sredniawa B, Pasyk S (2003) Heart rate variability in heart failure. Kardiol Pol 58: 10–16.
  103. Acharya U R, Kannathal N, Krishnan SM (2004) Comprehensive analysis of cardiac health using heart rate signals. Physiol Meas 25: 1139–1151.
  104. Wharton JM, Coleman RE, Strauss HC (1992) The role of the autonomic nervous system in sudden cardiac death. Trends Cardiovasc Med 2: 65–71.
  105. Billman GE, Hoskins RS (1989) Time-series analysis of heart rate variability during submaximal exercise. Evidence for reduced cardiac vagal tone in animals susceptible to ventricular fibrillation. Circulation 80: 146–157.
  106. Graham EM, Adami RR, McKenney SL, Jennings JM, Burd I, et al. (2014) Diagnostic accuracy of fetal heart rate monitoring in the identification of neonatal encephalopathy. Obstet Gynecol NIH 124: 507–513.
  107. Mani AR, Montagnese S, Jackson CD, Jenkins CW, Head IM, et al. (2009) Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 296:G330- G338.
  108. Celik A, Aytan P, Dursun H, Koc F, Ozbek K, et al. (2011) Heart Rate Variability and Heart Rate Turbulence in Hypothyroidism before and after Treatment. Ann Noninvasive Electrocardiol 16: 344–350.
  109. Gorman JM, Sloan RP (2000) Heart rate variability in depressive and anxiety disorders. Am Heart J 140: 77–83.
  110. Valenza G, Nardelli M, Bertschy G, Lanata A, Barbieri R, et al. (2014) Maximal-radius multiscale entropy of cardiovascular variability: A promising biomarker of pathological mood states in bipolar disorders. Conf Proc IEEE Eng Med Biol Soc 6663–6666.
  111. Moon E, Lee S-H, Kim D-H, Hwang B (2013) Comparative Study of Heart Rate Variability in Patients with Schizophrenia, Bipolar Disorder, Post-traumatic Stress Disorder, or Major Depressive Disorder. Clin Psychopharmacol Neurosci 11: 137–143.
  112. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W (2010) Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res 44: 168–176.
  113. Jindal RD, Vasko RC, Jennings JR, Fasiczka AL, Thase ME, et al. (2008) Heart rate variability in depressed elderly. Am J Geriatr Psychiatry 16: 861–866.
  114. Lowensohn RI, Weiss M, Hon EH (1977) Heart-rate variability in brain-damaged adults. Lancet 1: 626–628.
  115. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, et al. (2001) Depression, heart rate variability, and acute myocardial infarction. Circulation 104: 2024–2028.
  116. McCraty R (2011) Coherence: Bridging personal, social and global health. Act Nerv Super Rediviva 53: 85–102.
  117. Thayer JF, Lane RD (2000) A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord 61: 201–216.
  118. Thayer JF, Hansen AL, Saus-Rose E, Johnsen BH (2009) Heart Rate Variability, Prefrontal Neural Function, and Cognitive Performance: The Neurovisceral Integration Perspective on Self-regulation, Adaptation, and Health. Ann Behav Med  37: 141–153.
  119. Porges SW (2009) The polyvagal theory: new insights into adaptive reactions of the autonomic nervous system. Cleve Clin J Med 2: S86-S90.
  120. Börger N, van der Meere J, Ronner A, Alberts E, Geuze R,et al. (1999) Heart rate variability and sustained attention in ADHD children. J Abnorm Child Psychol 27: 25–33.
  121. McCraty R, Shaffer F (2015) Heart Rate Variability: New Perspectives on Physiological Mechanisms, Assessment of Self-regulatory Capacity, and Health risk. Glob Adv Heal Med 4: 46–61.
  122. Akaike H (1969) Fitting Autoregressive Models For Prediction. Ann Inst Stat Math 21: 243–247.
  123. Wang Y, Zhao X, O’Neil A, Turner A, Liu X, et al. (2013) Altered cardiac autonomic nervous function in depression. BMC Psychiatry 13:187.
  124. Sgoifo A, Carnevali L, Pico Alfonso M de los A, Amore M (2015) Autonomic dysfunction and heart rate variability in depression. Stress 18: 343–352.
  125. Messerotti Benvenuti S, Buodo G, Mennella R, Palomba D (2015) Somatic, but not cognitive–affective, symptoms are associated with reduced heart rate variability in individuals with dysphoria. Front Psychol 6: 599.
  126. Rottenberg J (2007) Cardiac vagal control in depression: A critical analysis. Biol Psychol 74: 200–211.
  127. Kemp AH, Quintana DS, Quinn CR, Hopkinson P, Harris AWF (2014) Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality. Front Psychol 5: 1387.
  128. Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S,et al. (2011) Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation. Int Rev Psychiatry 23: 424–436.
  129. George MS, Nahas Z, Borckardt JJ, Anderson B, Foust MJ, et al. (2007) Brain stimulation for the treatment of psychiatric disorders. Curr. Opin. Psychiatry 20:250–254.
  130. Daban C, Martinez-Aran A, Cruz N, Vieta E (2008) Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord 110: 1–15.
  131.  Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W (2010) Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res 44:168–76.
  132. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W (2010) Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res 44:168–76.
  133. Cohen H, Kaplan Z, Kotler M, Mittelman I, Osher Y, et al. (2003) Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord 5:138–143.
  134. Lee J-S, Kim B, Hong Y, Joo YH (2012) Heart rate variability in the subsyndromal depressive phase of bipolar disorder. Psychiatry Clin Neurosci 66: 361–366.
  135. Quintana DS, Westlye LT, Kaufmann T, Rustan ØG, Brandt CL, et al. (2016) Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls. Acta Psychiatr Scand 133: 44–52.
  136. Ramaekers D, Ector H, Vanhaecke J, van Cleemput J, van de Werf F (1996) Heart rate variability after cardiac transplantation in humans. Pacing Clin Electrophysiol 19: 2112–2119.
  137. Leipzig TJ, Lowensohn RI (1986) Heart rate variability in neurosurgical patients. Neurosurgery 19: 356–362.
  138. Acharya UR, Joseph P, Kannathal N, Lim C, Suri J (2007) Heart rate variability: A review. Med Biol Eng Comput 44: 1031–1051.
  139. Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, et al. (1982) Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 31: 339-345.
  140. Pfeifer MA, Cook D, Brodsky J, Tice D, Parrish D, et al. (1982) Quantitative evaluation of sympathetic and parasympathetic control of iris function. Diabetes Care 5: 518-528.
  141. Villareal RP, Liu BC, Massumi A (2002) Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep 4: 120-127.
  142. Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, et al. (2000) Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 86: 309-312.
  143. Wheeler T, Watkins PJ (1973) Cardiac denervation in diabetes. Br Med J 4: 584-586.
  144. Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M, et al. (1987) Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 45: 202-206.
  145. Hemingway H, Shipley M, Brunner E, Britton A, Malik M, et al. (2005) Does Autonomic Function Link Social Position to Coronary Risk?: The Whitehall II Study. Circulation 111: 3071-3077.
  146. Muller JE, Morrison J, Stone PH, Rude RE, Rosner B, et al. (1984) Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation 69: 740-747.
  147. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, et al. (1988) Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 6: 711-717.
  148. Bekheit S, Tangella M, El-Sakr A, Rasheed Q, Craelius W, et al. (1990) Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 119: 79-85.
  149. Coumel P, Hermida JS, Wennerblöm B, Leenhardt A, Maison-Blanche P, et al. (1991) Heart rate variability in left ventricular hypertrophy and heart failure, and the effects of beta-blockade. A non-spectral analysis of heart rate variability in the frequency domain and in the time domain. Eur Heart J 12: 412-422.
  150. Adamson PB, Huang MH, Vanoli E, Foreman RD, Schwartz PJ, et al. (1994) Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. Circulation 90: 976-982.
  151. Eryonucu B, Uzun K, Güler N, Bilge M (2001) Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients. Eur Respir J 17: 863-867.
  152. Zuanetti G, Latini R, Neilson JM, Schwartz PJ, Ewing DJ, et al. (1991) Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol 17: 604-612.
  153. Guo Z, Fu J, Zhao Y (2006) Therapeutic efficacy of oxymatrine on arrhythmia and heart rate variability in patients with coronary heart disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 26: 311-315.
  154. Vybiral T, Glaeser DH, Morris G, Hess KR, Yang K, et al. (1993) Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction. J Am Coll Cardiol 22: 1320-1326.
  155. Lotufo PA, Valiengo L, Benseñor IM, Brunoni AR (2012) A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs. Epilepsia 53: 272-282.
  156. Huang WL, Chang LR, Kuo TBJ, Lin YH, Chen YZ, et al. (2013) Impact of Antipsychotics and Anticholinergics on Autonomic Modulation in Patients With Schizophrenia. J Clin Psychopharmacol 33: 170-177.
  157. Linder JR, Sodhi SK, Haynes WG, Fiedorowicz JG (2014) Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder. Hum Psychopharmacol Clin Exp 29: 145-151.
  158. Davidson J, Watkins L, Owens M, Krulewicz S, Connor K, et al. (2018) Effects of paroxetine and venlafaxine XR on heart rate variability in depression. J Clin Psychopharmacol 25: 480-484.
  159. Van Zyl LT, Hasegawa T, Nagata K (2018) Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. Biopsychosoc Med 2: 12.
  160. Kemp AH, Quintana DS, Malhi GS (2011) Effects of Serotonin Reuptake Inhibitors on Heart Rate Variability: Methodological Issues, Medical Comorbidity, and Clinical Relevance. Biol Psychiatry 69: 25-26.
  161. Agelink M, Ullrich H, Baumann B, Strum S, Majewski T, et al. (2018) Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data. Psychopharmacology (Berl) 163: 151-156.
  162. Kemp AH, Outhred T, Saunders S, Brunoni AR, Nathan PJ, et al. (2014) Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects. Psychopharmacology (Berl) 231: 2281-2290.
  163. Chappell JC, Kovacs R, Haber H, Wright R, et al. (2013) Evaluation of the Effects of Duloxetine and Escitalopram on 24-Hour Heart Rate Variability. J Clin Psychopharmacol 33: 236-239.
  164. Terhardt J, Lederbogen F, Feuerhack A, Hamann-Weber B, Gilles M, et al. (2013) Heart Rate Variability During Antidepressant Treatment With Venlafaxine and Mirtazapine. Clin Neuropharmacol 36: 198-202.
  165. Khaspekova NB, Solov’ëva AD, Nedostup AV, San’kova TA (2005) Effect of clonazepam and antiarrhythmic drugs on heart rate variability in patients with paroxysmal atrial fibrillation. Kardiologiia 45: 35-40.
  166. Stefani M, Arima H, Mohamed A (2013) Withdrawal of anti-epileptic medications during video EEG monitoring does not alter ECG parameters or HRV. Epilepsy Res 106: 222-229.
  167. Larosa C, Infusino F, Sgueglia GA, Aurigemma C, Sestito A, et al. (2005) Effect of primary percutaneous coronary intervention versus thrombolysis on ventricular arrhythmias and heart rate variability in acute myocardial infarction. Ital Heart J 6: 629-633.
  168. Miller EB, Goss CF (2014) An Exploration of Physiological Responses to the Native American Flute.
  169. Wheat AL, Larkin KT (2010) Biofeedback of Heart Rate Variability and Related Physiology: A Critical Review. Appl Psychophysiol Biofeedback 35: 229-242.
  170. Posadzki P, Kuzdzal A, Lee MS, Ernst E (2015) Yoga for Heart Rate Variability: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Appl Psychophysiol Biofeedback 40: 239-249.
  171. Sutarto AP, Wahab MN, Zin NM (2012) Resonant Breathing Biofeedback Training for Stress Reduction Among Manufacturing Operators. Int J Occup Saf Ergon 18: 549-561.
Citation: Panday KR, Panday DR (2018) Heart Rate Variability (HRV). J Clin Exp Cardiolog 9:583.

Copyright: © 2018 Panday KR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top